Gene Therapeutic Strategies for Neuroprotection: Implications for Parkinson's Disease
Open Access
- 31 March 1997
- journal article
- review article
- Published by Elsevier BV in Experimental Neurology
- Vol. 144 (1), 58-68
- https://doi.org/10.1006/exnr.1996.6389
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's diseaseBrain Research, 1995
- Expression of bcl-2 From a Defective Herpes Simplex Virus–1 Vector Limits Neuronal Death in Focal Cerebral IschemiaStroke, 1995
- Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in ratDevelopmental Brain Research, 1995
- Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinsonʼs diseaseNeuroReport, 1994
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neuronsNeuron, 1990
- A Prominent Serine-rich Region in Vmw175, the Major Transcriptional Regulator Protein of Herpes Simplex Virus Type 1, is not Essential for Virus Growth in Tissue CultureJournal of General Virology, 1990
- The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (mptp) and its relevance to parkinson's diseaseNeurochemistry International, 1987